UTI Drugs Market 2027 Bys Drug Class, Clinical Indication, Distribution Channel and Geography | The Insight Partners

UTI Drugs Market to 2027 - Global Analysis and Forecasts bys Drug Class (Quinolones, Aminoglycosides, ?-Lactam, Azoles, Others); Clinical Indication (Urethritis, Cystitis, Pyelonephritis); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Commerce) and Geography

Report Code: TIPRE00004547 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
UTI stands for urinary tract infection is caused in the any part of urinary system such as kidney, bladder, ureter and urethra. Females get more affected by UTI than males. This infection is caused by bacteria or fungi. Urinary tract infections are not much serious, however these infections are transmitted from one person to another leading to various life threatening diseases if not treated appropriately. According to world health organization approximately 50% of female get affected by the UTI. As a treatment of UTI various antibiotics are used such as amoxicillin.

MARKET DYNAMICS
The global UTI drugs market is expected to have increasing growth in upcoming years due to the increase in UTI infection caused due to the hospitals and organisms (nosocomial infection), rise in child birth, obesity, catheter associated UTI are others. While there are some constrains such as inadequate medication system, increase in chronic diseases which can harm the market growth. On the other hand, the new development in medication has created the new opportunities in the market.

MARKET SCOPE
The "Global UTI Drugs Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global pharmaceutical market trend analysis. The report aims to provide an overview of UTI drugs market with detailed market segmentation by drug class, clinical indications, distribution channels and geography. The global UTI drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading UTI drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global UTI drugs market is segmented on the basis of drug class, clinical indications, and end users. Based on drug class, the market is segmented as quinolones, aminoglycosides, ?-lactam, azoles, and others. On the basis of clinical indication, the global UTI drugs market is segmented into urethritis, cystitis, and pyelonephritis. Based on end users, the market segmented into hospitals pharmacies, retail pharmacies, e-commerce.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global UTI drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The UTI drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting UTI drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the UTI drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the UTI drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from UTI drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for UTI drugs in the global market. Below mentioned is the list of few companies engaged in the UTI drugs market.

The report also includes the profiles of key UTI drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Johnson & Johnsons Private Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 UTI Drugs Market - By Drug Class
1.3.2 UTI Drugs Market - By Clinical Indication
1.3.3 UTI Drugs Market - By Distribution Channel
1.3.4 UTI Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. UTI DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. UTI DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. UTI DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. UTI DRUGS - GLOBAL MARKET OVERVIEW
6.2. UTI DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. UTI DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. QUINOLONES
7.3.1. Overview
7.3.2. Quinolones Market Forecast and Analysis
7.4. AMINOGLYCOSIDES
7.4.1. Overview
7.4.2. Aminoglycosides Market Forecast and Analysis
7.5. ?-LACTAM
7.5.1. Overview
7.5.2. - -Lactam Market Forecast and Analysis
7.6. AZOLES
7.6.1. Overview
7.6.2. Azoles Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. UTI DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - CLINICAL INDICATION
8.1. OVERVIEW
8.2. CLINICAL INDICATION MARKET FORECASTS AND ANALYSIS
8.3. URETHRITIS
8.3.1. Overview
8.3.2. Urethritis Market Forecast and Analysis
8.4. CYSTITIS
8.4.1. Overview
8.4.2. Cystitis Market Forecast and Analysis
8.5. PYELONEPHRITIS
8.5.1. Overview
8.5.2. Pyelonephritis Market Forecast and Analysis
9. UTI DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. E-COMMERCE
9.5.1. Overview
9.5.2. e-Commerce Market Forecast and Analysis
10. UTI DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America UTI Drugs Market Overview
10.1.2 North America UTI Drugs Market Forecasts and Analysis
10.1.3 North America UTI Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America UTI Drugs Market Forecasts and Analysis - By Clinical Indication
10.1.5 North America UTI Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America UTI Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States UTI Drugs Market
10.1.6.1.1 United States UTI Drugs Market by Drug Class
10.1.6.1.2 United States UTI Drugs Market by Clinical Indication
10.1.6.1.3 United States UTI Drugs Market by Distribution Channel
10.1.6.2 Canada UTI Drugs Market
10.1.6.2.1 Canada UTI Drugs Market by Drug Class
10.1.6.2.2 Canada UTI Drugs Market by Clinical Indication
10.1.6.2.3 Canada UTI Drugs Market by Distribution Channel
10.1.6.3 Mexico UTI Drugs Market
10.1.6.3.1 Mexico UTI Drugs Market by Drug Class
10.1.6.3.2 Mexico UTI Drugs Market by Clinical Indication
10.1.6.3.3 Mexico UTI Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe UTI Drugs Market Overview
10.2.2 Europe UTI Drugs Market Forecasts and Analysis
10.2.3 Europe UTI Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe UTI Drugs Market Forecasts and Analysis - By Clinical Indication
10.2.5 Europe UTI Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe UTI Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany UTI Drugs Market
10.2.6.1.1 Germany UTI Drugs Market by Drug Class
10.2.6.1.2 Germany UTI Drugs Market by Clinical Indication
10.2.6.1.3 Germany UTI Drugs Market by Distribution Channel
10.2.6.2 France UTI Drugs Market
10.2.6.2.1 France UTI Drugs Market by Drug Class
10.2.6.2.2 France UTI Drugs Market by Clinical Indication
10.2.6.2.3 France UTI Drugs Market by Distribution Channel
10.2.6.3 Italy UTI Drugs Market
10.2.6.3.1 Italy UTI Drugs Market by Drug Class
10.2.6.3.2 Italy UTI Drugs Market by Clinical Indication
10.2.6.3.3 Italy UTI Drugs Market by Distribution Channel
10.2.6.4 Spain UTI Drugs Market
10.2.6.4.1 Spain UTI Drugs Market by Drug Class
10.2.6.4.2 Spain UTI Drugs Market by Clinical Indication
10.2.6.4.3 Spain UTI Drugs Market by Distribution Channel
10.2.6.5 United Kingdom UTI Drugs Market
10.2.6.5.1 United Kingdom UTI Drugs Market by Drug Class
10.2.6.5.2 United Kingdom UTI Drugs Market by Clinical Indication
10.2.6.5.3 United Kingdom UTI Drugs Market by Distribution Channel
10.2.6.6 Rest of Europe UTI Drugs Market
10.2.6.6.1 Rest of Europe UTI Drugs Market by Drug Class
10.2.6.6.2 Rest of Europe UTI Drugs Market by Clinical Indication
10.2.6.6.3 Rest of Europe UTI Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific UTI Drugs Market Overview
10.3.2 Asia-Pacific UTI Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific UTI Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific UTI Drugs Market Forecasts and Analysis - By Clinical Indication
10.3.5 Asia-Pacific UTI Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific UTI Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia UTI Drugs Market
10.3.6.1.1 Australia UTI Drugs Market by Drug Class
10.3.6.1.2 Australia UTI Drugs Market by Clinical Indication
10.3.6.1.3 Australia UTI Drugs Market by Distribution Channel
10.3.6.2 China UTI Drugs Market
10.3.6.2.1 China UTI Drugs Market by Drug Class
10.3.6.2.2 China UTI Drugs Market by Clinical Indication
10.3.6.2.3 China UTI Drugs Market by Distribution Channel
10.3.6.3 India UTI Drugs Market
10.3.6.3.1 India UTI Drugs Market by Drug Class
10.3.6.3.2 India UTI Drugs Market by Clinical Indication
10.3.6.3.3 India UTI Drugs Market by Distribution Channel
10.3.6.4 Japan UTI Drugs Market
10.3.6.4.1 Japan UTI Drugs Market by Drug Class
10.3.6.4.2 Japan UTI Drugs Market by Clinical Indication
10.3.6.4.3 Japan UTI Drugs Market by Distribution Channel
10.3.6.5 South Korea UTI Drugs Market
10.3.6.5.1 South Korea UTI Drugs Market by Drug Class
10.3.6.5.2 South Korea UTI Drugs Market by Clinical Indication
10.3.6.5.3 South Korea UTI Drugs Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific UTI Drugs Market
10.3.6.6.1 Rest of Asia-Pacific UTI Drugs Market by Drug Class
10.3.6.6.2 Rest of Asia-Pacific UTI Drugs Market by Clinical Indication
10.3.6.6.3 Rest of Asia-Pacific UTI Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa UTI Drugs Market Overview
10.4.2 Middle East and Africa UTI Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa UTI Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa UTI Drugs Market Forecasts and Analysis - By Clinical Indication
10.4.5 Middle East and Africa UTI Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa UTI Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa UTI Drugs Market
10.4.6.1.1 South Africa UTI Drugs Market by Drug Class
10.4.6.1.2 South Africa UTI Drugs Market by Clinical Indication
10.4.6.1.3 South Africa UTI Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia UTI Drugs Market
10.4.6.2.1 Saudi Arabia UTI Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia UTI Drugs Market by Clinical Indication
10.4.6.2.3 Saudi Arabia UTI Drugs Market by Distribution Channel
10.4.6.3 U.A.E UTI Drugs Market
10.4.6.3.1 U.A.E UTI Drugs Market by Drug Class
10.4.6.3.2 U.A.E UTI Drugs Market by Clinical Indication
10.4.6.3.3 U.A.E UTI Drugs Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa UTI Drugs Market
10.4.6.4.1 Rest of Middle East and Africa UTI Drugs Market by Drug Class
10.4.6.4.2 Rest of Middle East and Africa UTI Drugs Market by Clinical Indication
10.4.6.4.3 Rest of Middle East and Africa UTI Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America UTI Drugs Market Overview
10.5.2 South and Central America UTI Drugs Market Forecasts and Analysis
10.5.3 South and Central America UTI Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America UTI Drugs Market Forecasts and Analysis - By Clinical Indication
10.5.5 South and Central America UTI Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America UTI Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil UTI Drugs Market
10.5.6.1.1 Brazil UTI Drugs Market by Drug Class
10.5.6.1.2 Brazil UTI Drugs Market by Clinical Indication
10.5.6.1.3 Brazil UTI Drugs Market by Distribution Channel
10.5.6.2 Argentina UTI Drugs Market
10.5.6.2.1 Argentina UTI Drugs Market by Drug Class
10.5.6.2.2 Argentina UTI Drugs Market by Clinical Indication
10.5.6.2.3 Argentina UTI Drugs Market by Distribution Channel
10.5.6.3 Rest of South and Central America UTI Drugs Market
10.5.6.3.1 Rest of South and Central America UTI Drugs Market by Drug Class
10.5.6.3.2 Rest of South and Central America UTI Drugs Market by Clinical Indication
10.5.6.3.3 Rest of South and Central America UTI Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. UTI DRUGS MARKET, KEY COMPANY PROFILES
12.1. BAYER AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CIPLA INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. DR. REDDY’S LABORATORIES LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JOHNSON AND JOHNSONS SERVICES, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GLAXOSMITHKLINE PHARMACEUTICALS LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BOEHRINGER INGELHEIM GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. Novartis AG
3. Pfizer Inc.
4. F. Hoffmann-La Roche Ltd
5. AstraZeneca Plc
6. Cipla Inc.
7. Dr. Reddy's Laboratories Ltd.
8. Johnson and Johnsons Services, Inc.
9. GlaxoSmithKline Pharmaceuticals Ltd.
10. Boehringer Ingelheim GmbH